Titan America SA Common Shares (TTAM)
17.61
+0.74 (4.39%)
NYSE · Last Trade: Jan 12th, 2:28 AM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025
